Fundraising Fox

Biotech Late Stage Investors & VC Firms

652 firms in this list, with a median first check of $1M. 131 of them lead rounds. Generated from verified public data and updated continuously.

redalpine
ZugSeed–Late Stage$108K – $2.2M
27 people
Amadeus Capital Partners
LondonPre-Seed–Late Stage$50K – $12.7M
27 people
Supernova Invest
ParisPre-Seed–Late Stage
33 people
KAYA
PraguePre-Seed–Late Stage$108K – $3.2M
15 people
Blue Venture Funds
ChicagoSeed–Late Stage$1M – $20M
31 people
b2venture
BerlinPre-Seed–Late Stage$270K – $5.4M
36 people
Vertex Ventures China
SingaporePre-Seed–Late Stage$2M – $85M
8 people
Pitango
Tel AvivPre-Seed–Late Stage$4M – $100M
40 people
Medicxi
LondonPre-Seed–Late Stage
39 people
Oxford Finance LLC
AlexandriaSeed–Late Stage$5M – $125M
45 people
Berkeley Frontier
BerkeleyPre-Seed–Late Stage
41 people
Agent Capital
WalthamPre-Seed–Late Stage
26 people
PMV
BrusselsPre-Seed–Late Stage
6 people
B4 Capital
Pre-Seed–Late Stage$10M – $50M
2 people
Cross Creek Advisors
Salt Lake CitySeries B–Late Stage
21 people
Artis Ventures
San FranciscoSeed–Late Stage$50K – $25M
8 people
SHS Capital
TübingenGrowth–Late Stage$10M – $50M
44 people
Kreos Capital
LondonSeries A–Late Stage
43 people
LSP (Life Sciences Partners)
AmsterdamSeries A–Late Stage$10.8M – $64.8M
41 people
RiverVest Venture Partners
St. LouisPre-Seed–Late Stage$500K – $3M
22 people
Ahren Innovation Capital
Cambridge, CambridgeshirePre-Seed–Late Stage
34 people
The Column Group
San FranciscoPre-Seed–Late Stage$30M
26 people
JAZZ Venture Partners
San FranciscoSeed–Late Stage$100K – $20M
16 people
S32
Palo AltoSeries A–Late Stage
25 people

Related lists

Data sourced from public filings and firms' own websites — see our methodology.